NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Developing and Sustaining an Effective and Resilient Oncology Careforce

Developing and Sustaining an Effective and Resilient Oncology Careforce

Proceedings of a Workshop

; Editors: Sharyl J. Nass, Rapporteur, Margie Patlak, Rapporteur, Emily Zevon, Rapporteur, and Erin Balogh, Rapporteur.

Washington (DC): National Academies Press (US); .
ISBN-13: 978-0-309-49604-9ISBN-10: 0-309-49604-7

The oncology careforce faces challenges as population growth in the U.S. contributes to increases in the number of patients diagnosed with cancer. Significant advances in cancer research, screening and diagnostic practices, and treatment have led to the age-adjusted declining mortality rate from cancer. However, as the field continues to develop and advance, cancer care has become more complex than ever before. There is a growing concern regarding the U.S. health care system's capacity to deliver high-quality cancer care to the increasing number of patients. The National Academies convened a workshop on February 11-12, 2019 to explore trends in cancer care and identify opportunities for improvement in the rapidly developing oncology careforce. Discussions at the workshop primarily focused on trends in demographics, the careforce, and oncology practice, as well as implications for the future of cancer care and strategies to improve the organization and delivery of cancer care. Opportunities to change policy and leverage technologies in oncology were also identified. This publication summarizes the presentations and discussions from the workshop.

This activity was supported by Contract No. 200-2011-38807 (Task Order No. 75D30118F00071) and Contract No. HHSN263201800029I (Task Order No. HHSN26300008) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research, American Cancer Society, American College of Radiology, American Society of Clinical Oncology, Association of American Cancer Institutes, Association of Community Cancer Centers, Bristol-Myers Squibb, Cancer Support Community, CEO Roundtable on Cancer, Flatiron Health, Helsinn Therapeutics (U.S.), Inc., LIVESTRONG Foundation, Merck, National Comprehensive Cancer Network, Novartis Oncology, Oncology Nursing Society, and Pfizer Inc. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

Suggested citation:

National Academies of Sciences, Engineering, and Medicine. 2019. Developing and sustaining an effective and resilient oncology careforce: Proceedings of a workshop. Washington, DC: The National Academies Press.

Digital Object Identifier:

Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313;

Printed in the United States of America

Copyright 2019 by the National Academy of Sciences. All rights reserved.
Bookshelf ID: NBK547159PMID: 31577398DOI: 10.17226/25533


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.7M)

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...